[HTML][HTML] Mechanisms of disease: pulmonary arterial hypertension

RT Schermuly, HA Ghofrani, MR Wilkins… - Nature Reviews …, 2011 - nature.com
Our understanding of, and approach to, pulmonary arterial hypertension has undergone a
paradigm shift in the past decade. Once a condition thought to be dominated by increased …

Advances in therapeutic interventions for patients with pulmonary arterial hypertension

M Humbert, EMT Lau, D Montani, X Jaïs, O Sitbon… - Circulation, 2014 - Am Heart Assoc
Pulmonary arterial hypertension (PAH) is a disease characterized by progressive
remodeling of the distal pulmonary arteries, resulting in the loss of vascular cross-sectional …

Inflammation in pulmonary arterial hypertension

LC Price, SJ Wort, F Perros, P Dorfmüller, A Huertas… - Chest, 2012 - Elsevier
Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling
of the precapillary pulmonary arteries, with excessive proliferation of vascular cells. Although …

Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies

SL Archer, EK Weir, MR Wilkins - Circulation, 2010 - Am Heart Assoc
Pulmonary arterial hypertension (PAH) is a syndrome in which pulmonary arterial
obstruction increases pulmonary vascular resistance, which leads to right ventricular (RV) …

Ventricular septal defect

DJ Penny, GW Vick - The Lancet, 2011 - thelancet.com
Ventricular septal defects account for up to 40% of all congenital cardiac malformations. The
diagnosis encompasses a broad range of anomalies, including isolated defects and those …

Targeted therapies in pulmonary arterial hypertension

D Montani, MC Chaumais, C Guignabert… - Pharmacology & …, 2014 - Elsevier
Pulmonary arterial hypertension (PAH) is a rare disorder characterized by progressive
obliteration of small pulmonary arteries that leads to elevated pulmonary arterial pressure …

Stem cells and cell therapies in lung biology and lung diseases

DJ Weiss, I Bertoncello, Z Borok, C Kim… - Proceedings of the …, 2011 - atsjournals.org
EXECUTIVE SUMMARY The University of Vermont College of Medicine and the Vermont
Lung Center, with support of the National Heart, Lung, and Blood Institute (NHLBI), the …

C-kit–positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension

D Montani, F Perros, N Gambaryan… - American journal of …, 2011 - atsjournals.org
Rationale: C-kit+ cells, including bone marrow (BM)–derived progenitors and mast cells,
may participate in vascular remodelling. Because recent studies suggest that c-kit may be a …

Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence

F Sabatier, L Camoin‐Jau, F Anfosso… - Journal of cellular …, 2009 - Wiley Online Library
• Introduction• Dynamics between endothelial injury and repair: the response to injury theory
'revisited'• Emerging biomarkers reflecting the dynamics between endothelial injury and …

Pathophysiology of congenital heart disease in the adult: part I: Shunt lesions

RJ Sommer, ZM Hijazi, JF Rhodes Jr - Circulation, 2008 - Am Heart Assoc
Congenital heart disease is common, occurring in 8 of 1000 live births. 1 With the successes
in cardiothoracic surgery over the past 3 decades and the ongoing improvements in the …